Atlas Trials

Efficacy and Safety Evaluation of Paxlovid for COVID-19: a Real-world Case-control Study

Clinical trial NCT05532852 · UNKNOWN

Trial details

NCT number
NCT05532852
Sponsor
Ruijin Hospital
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
COVID-19 Pneumonia
Start date
2022-07-01
Primary completion
2023-06-01
Enrollment
728

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.